This chapter explains the potential of natural, plant-based medicinal treatments in the management of chronic diseases in the coming time. It addresses the advantages of natural therapies and their growing importance in effectively treating chronic conditions. It has shown the rising prevalence of chronic diseases in India and worldwide. It provides evidence-based studies of popular plant-based treatments for chronic conditions such as cardiovascular diseases, lung diseases, inflammatory bowel diseases, diabetes, cancer, and others. Furthermore, covered in extensive detail are the well-known phytomedicines Ashwagandha (Withania somnifera), Tulsi (Ocimum tenuiflorum, Ocimum sanctum L., or Ocimum gratissimum), Turmeric (Curcuma longa), Amla (Phyllanthus emblica), Brahmi (Bacopa monnieri), Ginseng (Panax ginseng), and Gingko (Ginkgo biloba). The chapter also clarifies the molecular processes of natural active substances, including curcumin, graviola, resveratrol, berberine, and others, in targeting several signaling pathways to cure different chronic diseases. It also explains combination drug therapy, nanotechnology, and AI-driven insights to transform conventional medicine. Overall, this chapter shows how plant-based therapeutics could provide safer, more sustainable, and more effective treatments in the future.

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Shaping the Future of Chronic Diseases: A Phyto-Mediated Natural Approach

  • Priyanka Raju Chougule

摘要

This chapter explains the potential of natural, plant-based medicinal treatments in the management of chronic diseases in the coming time. It addresses the advantages of natural therapies and their growing importance in effectively treating chronic conditions. It has shown the rising prevalence of chronic diseases in India and worldwide. It provides evidence-based studies of popular plant-based treatments for chronic conditions such as cardiovascular diseases, lung diseases, inflammatory bowel diseases, diabetes, cancer, and others. Furthermore, covered in extensive detail are the well-known phytomedicines Ashwagandha (Withania somnifera), Tulsi (Ocimum tenuiflorum, Ocimum sanctum L., or Ocimum gratissimum), Turmeric (Curcuma longa), Amla (Phyllanthus emblica), Brahmi (Bacopa monnieri), Ginseng (Panax ginseng), and Gingko (Ginkgo biloba). The chapter also clarifies the molecular processes of natural active substances, including curcumin, graviola, resveratrol, berberine, and others, in targeting several signaling pathways to cure different chronic diseases. It also explains combination drug therapy, nanotechnology, and AI-driven insights to transform conventional medicine. Overall, this chapter shows how plant-based therapeutics could provide safer, more sustainable, and more effective treatments in the future.